escitalopram has been researched along with Liver Neoplasms in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chan, HL; Chen, LJ; Chen, VC; Hsu, TC; Huang, JY; Lin, CF; Stewart, R; Tzang, BS | 1 |
| Chen, VC; Hsu, TC; Huang, JY; Huang, SL; McIntyre, RS; Tzang, BS | 1 |
2 other study(ies) available for escitalopram and Liver Neoplasms
| Article | Year |
|---|---|
Protective Effect of Escitalopram on Hepatocellular Carcinoma by Inducing Autophagy.
Topics: Animals; Autophagy; Carcinoma, Hepatocellular; Cell Line, Tumor; Cohort Studies; Escitalopram; Humans; Liver Neoplasms; Mice; Mice, SCID | 2022 |
Combined Administration of Escitalopram Oxalate and Nivolumab Exhibits Synergistic Growth-Inhibitory Effects on Liver Cancer Cells through Inducing Apoptosis.
Topics: Animals; Apoptosis; Escitalopram; Humans; Liver Neoplasms; Mice; Mice, Nude; Nivolumab | 2023 |